Association of psychotropic drug use and risk of recurrent falls.

<p>German national health interview and examination survey 2008–2011 (DEGS1).</p

Descriptive characteristics of study population.

<p>German national health interview and examination survey 2008–2011 (DEGS1).</p

Association of psychotropic drug use with falls among older adults in Germany. Results of the German Health Interview and Examination Survey for Adults 2008-2011 (DEGS1)

<div><p>Purpose</p><p>To investigate the association of psychotropic drug use with falls among older adults in Germany based on data from the National Health Interview and Examination Survey for Adults 2008–2011 (DEGS1).</p><p>Methods</p><p>DEGS1 collected data on drug use in the past 7 days and on falls occurred in the last 12 months. Study participants were older adults aged 65–79 years with complete data on drug use and falls (N = 1,833). Odds ratio (OR) and 95% confidence intervals (95% CI) were derived from logistic regression models adjusting for potential confounders including socio-demographic characteristics, health-related behaviors (alcohol drinking), body mass index and health conditions (frailty, vision impairment, disability, polypharmacy, blood pressure) as well as use of potential falls-risk-increasing drugs. SPSS complex sample methods were used for statistical analysis.</p><p>Results</p><p>Compared to people without falls, people with falls (n = 370) had a higher psychotropic drug use (33.1% vs. 20.7%, p < .001). After adjusting for potential confounders, use of psychotropic drugs overall was associated with a higher risk of falls (OR 1.64, 95% CI 1.14–2.37). This was particularly true for the use of synthetic psychotropic drugs (1.57, 1.08–2.28), antidepressants overall (2.88, 1.63–5.09) or synthetic antidepressants (2.66, 1.50–4.73), specifically, selective serotonin reuptake inhibitors (SSRIs) (6.22, 2.28–17.0). Similar results were found for recurrent falls.</p><p>Conclusions</p><p>Use of psychotropic drugs overall, especially synthetic antidepressants like SSRIs, is associated with higher risks of falls and recurrent falls among community dwelling older adults aged 65–79 years in Germany.</p></div

Association of psychotropic drug use with risks of falls.

<p>German national health interview and examination survey 2008–2011 (DEGS1).</p

Prevalence of psychotropic drug use and potential falls-risk-increasing drug use among older adults with and without falls.

<p>German national health interview and examination survey 2008–2011 (DEGS1).</p

Age-classified current MHT use prevalence in the two German national health surveys conducted before (1997–1999) and after (2003–2004) the EPT-WHI study

<p><b>Copyright information:</b></p><p>Taken from "Differences in Menopausal Hormone Therapy Use among Women in Germany between 1998 and 2003"</p><p>http://www.biomedcentral.com/1472-6874/7/19</p><p>BMC Women's Health 2007;7():19-19.</p><p>Published online 18 Oct 2007</p><p>PMCID:PMC2233614.</p><p></p> MHT = Menopausal hormone therapy. EPT-WHI = combined estrogen plus progestin therapy arm of the Women's Health Initiative randomized controlled trial. * p < 0.05, ** p < 0.001, compared to age specific prevalence in the 1997–1999 survey

Asthma management practices in adults – findings from the German Health Update (GEDA) 2010 and the German National Health Interview and Examination Survey (DEGS1) 2008–2011

<p><i>Objectives</i>: In Germany, population-wide data on adherence to national asthma management guidelines are lacking, and performance measures (PM) for quality assurance in asthma care are systematically monitored for patients with German national asthma disease management program (DMP) enrollment only. We used national health survey data to assess variation in asthma care PM with respect to patient characteristics and care context, including DMP enrollment. <i>Methods</i>: Among adults 18–79 years with self-reported physician-diagnosed asthma in the past 12 months identified from a recent German National Health Interview Survey (GEDA 2010: <i>N</i> = 1096) and the German National Health interview and Examination Survey 2008–2011 (DEGS1: <i>N</i> = 333), variation in asthma care PM was analyzed using logistic regression analysis. <i>Results</i>: Overall, 38.4% (95% confidence interval: 32.5–44.6%) of adults with asthma were on current inhaled corticosteroid therapy. Regarding non-drug asthma management, low coverage was observed for inhaler technique monitoring (35.2%; 31.2–39.3%) and for provision of an asthma management plan (27.3%; 24.2–30.7%), particularly among those with low education. Specific PM were more complete among persons with than without asthma DMP enrollment (adjusted odds ratios ranging up to 10.19; 5.23–19.86), even if asthma patients were regularly followed in a different care context. <i>Conclusions</i>: Guideline adherence appears to be suboptimal, particularly with respect to PM related to patient counseling. Barriers to the translation of recommendations into practice need to be identified and continuous monitoring of asthma care PM at the population level needs to be established.</p

Additional file 1: Table S1. of Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11

Dietary Variables in GNHIES98 and DEGS1 (PDF 8 kb

Additional file 3: Table S4. of Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11

Linear regression models for total cholesterol. Table S5. Linear regression models for triglycerides. Table S6. Linear regression models for high density lipoprotein. (DOCX 47 kb

Additional file 2: Table S2. of Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11

Linear regression models for serum lipids with survey wave (DEGS1 vs. GNHIES98) as independent variable based on multiple imputed data. Table S3. Linear regression models for serum lipids with survey wave (DEGS1 vs. GNHIES98) as independent variable and additional explanatory variables. (DOCX 29 kb